Concepts (246)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mitochondria | 8 | 2012 | 1282 | 1.480 |
Why?
|
| Reactive Oxygen Species | 10 | 2016 | 987 | 1.290 |
Why?
|
| Glycolysis | 7 | 2018 | 519 | 1.060 |
Why?
|
| Isothiocyanates | 3 | 2016 | 44 | 1.010 |
Why?
|
| Glutathione | 6 | 2016 | 368 | 0.990 |
Why?
|
| Stromal Cells | 3 | 2013 | 825 | 0.690 |
Why?
|
| Tumor Suppressor Protein p53 | 6 | 2016 | 3552 | 0.640 |
Why?
|
| Oxidation-Reduction | 6 | 2014 | 717 | 0.630 |
Why?
|
| Organelle Biogenesis | 1 | 2016 | 32 | 0.580 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 | 2016 | 2390 | 0.520 |
Why?
|
| Chromosome Deletion | 2 | 2016 | 1005 | 0.510 |
Why?
|
| Cell Survival | 8 | 2012 | 3045 | 0.450 |
Why?
|
| Neoplasms | 11 | 2023 | 15193 | 0.440 |
Why?
|
| Cystine | 1 | 2012 | 34 | 0.410 |
Why?
|
| NADPH Oxidases | 1 | 2012 | 146 | 0.400 |
Why?
|
| Antineoplastic Agents | 9 | 2023 | 14289 | 0.400 |
Why?
|
| Cell Communication | 2 | 2012 | 509 | 0.400 |
Why?
|
| DNA, Mitochondrial | 4 | 2009 | 311 | 0.400 |
Why?
|
| Glutamine | 1 | 2011 | 299 | 0.350 |
Why?
|
| Lignans | 1 | 2009 | 15 | 0.350 |
Why?
|
| Pyruvates | 1 | 2009 | 28 | 0.350 |
Why?
|
| Hexokinase | 1 | 2009 | 36 | 0.340 |
Why?
|
| Reactive Nitrogen Species | 1 | 2008 | 14 | 0.330 |
Why?
|
| Energy Metabolism | 3 | 2018 | 992 | 0.320 |
Why?
|
| Nitrosamines | 1 | 2008 | 50 | 0.320 |
Why?
|
| Cell Respiration | 3 | 2016 | 52 | 0.320 |
Why?
|
| Biphenyl Compounds | 1 | 2009 | 194 | 0.310 |
Why?
|
| Bone Marrow Cells | 1 | 2012 | 943 | 0.310 |
Why?
|
| Carcinogens | 2 | 2008 | 384 | 0.310 |
Why?
|
| Bile Acids and Salts | 1 | 2009 | 246 | 0.300 |
Why?
|
| Chalcones | 1 | 2006 | 7 | 0.290 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2014 | 2359 | 0.290 |
Why?
|
| Boron Compounds | 1 | 2006 | 59 | 0.270 |
Why?
|
| Apoptosis | 8 | 2013 | 7591 | 0.270 |
Why?
|
| Esophagus | 1 | 2009 | 553 | 0.270 |
Why?
|
| Drug Delivery Systems | 1 | 2009 | 669 | 0.260 |
Why?
|
| Proteasome Inhibitors | 1 | 2006 | 231 | 0.250 |
Why?
|
| Radiation Tolerance | 1 | 2008 | 629 | 0.250 |
Why?
|
| Drug Resistance, Neoplasm | 5 | 2023 | 5178 | 0.240 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2005 | 182 | 0.240 |
Why?
|
| Epithelial Cells | 2 | 2009 | 1818 | 0.240 |
Why?
|
| Pancreatic Neoplasms | 5 | 2014 | 5061 | 0.240 |
Why?
|
| Heat Shock Transcription Factors | 1 | 2023 | 51 | 0.230 |
Why?
|
| Proteostasis | 1 | 2023 | 52 | 0.220 |
Why?
|
| Endoribonucleases | 1 | 2023 | 107 | 0.220 |
Why?
|
| Leukemia | 1 | 2011 | 1635 | 0.220 |
Why?
|
| Genomic Instability | 1 | 2005 | 519 | 0.210 |
Why?
|
| Mutation | 6 | 2016 | 15179 | 0.210 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2023 | 460 | 0.200 |
Why?
|
| RNA, Small Interfering | 5 | 2012 | 2216 | 0.200 |
Why?
|
| Animals | 16 | 2018 | 59536 | 0.190 |
Why?
|
| Oxidative Phosphorylation | 2 | 2012 | 253 | 0.190 |
Why?
|
| DNA Damage | 2 | 2005 | 1954 | 0.180 |
Why?
|
| HL-60 Cells | 2 | 2011 | 302 | 0.180 |
Why?
|
| Signal Transduction | 5 | 2014 | 11965 | 0.170 |
Why?
|
| Superoxide Dismutase | 2 | 2012 | 266 | 0.170 |
Why?
|
| Immunoblotting | 4 | 2016 | 886 | 0.170 |
Why?
|
| Cell Line, Tumor | 10 | 2018 | 14551 | 0.160 |
Why?
|
| Humans | 28 | 2023 | 261506 | 0.160 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2018 | 216 | 0.150 |
Why?
|
| Sirtuin 2 | 1 | 2016 | 19 | 0.140 |
Why?
|
| Peroxiredoxins | 1 | 2016 | 17 | 0.140 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2023 | 1331 | 0.140 |
Why?
|
| Oncogenes | 2 | 2011 | 673 | 0.140 |
Why?
|
| Glutaminase | 1 | 2016 | 47 | 0.140 |
Why?
|
| Mice | 10 | 2018 | 34495 | 0.140 |
Why?
|
| mRNA Cleavage and Polyadenylation Factors | 1 | 2016 | 60 | 0.140 |
Why?
|
| Enzyme Inhibitors | 1 | 2023 | 1879 | 0.140 |
Why?
|
| Boronic Acids | 3 | 2006 | 362 | 0.130 |
Why?
|
| Esophageal Neoplasms | 1 | 2009 | 3168 | 0.130 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2016 | 275 | 0.130 |
Why?
|
| Transfection | 3 | 2012 | 2944 | 0.130 |
Why?
|
| Endoplasmic Reticulum | 2 | 2005 | 308 | 0.120 |
Why?
|
| Flow Cytometry | 3 | 2012 | 3033 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2016 | 641 | 0.120 |
Why?
|
| NADPH Oxidase 1 | 1 | 2012 | 7 | 0.110 |
Why?
|
| Enzyme Activation | 3 | 2012 | 1764 | 0.110 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2012 | 26 | 0.110 |
Why?
|
| HEK293 Cells | 2 | 2018 | 1489 | 0.110 |
Why?
|
| Cell Death | 2 | 2018 | 671 | 0.110 |
Why?
|
| Cell Line | 2 | 2012 | 5114 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2014 | 476 | 0.100 |
Why?
|
| Neoplastic Stem Cells | 2 | 2011 | 1443 | 0.100 |
Why?
|
| Tetracycline | 1 | 2012 | 90 | 0.100 |
Why?
|
| NADH Dehydrogenase | 1 | 2011 | 15 | 0.100 |
Why?
|
| Buthionine Sulfoximine | 1 | 2011 | 41 | 0.100 |
Why?
|
| Interleukin-1beta | 1 | 2013 | 300 | 0.100 |
Why?
|
| Culture Media, Conditioned | 1 | 2012 | 260 | 0.100 |
Why?
|
| Electron Transport Complex I | 1 | 2011 | 62 | 0.100 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2018 | 8873 | 0.100 |
Why?
|
| Molecular Weight | 1 | 2012 | 629 | 0.100 |
Why?
|
| Genes, ras | 1 | 2014 | 667 | 0.100 |
Why?
|
| HCT116 Cells | 2 | 2016 | 348 | 0.100 |
Why?
|
| Models, Biological | 2 | 2011 | 3254 | 0.100 |
Why?
|
| Cysteine | 1 | 2012 | 214 | 0.100 |
Why?
|
| Genes, Neoplasm | 1 | 2012 | 324 | 0.090 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2018 | 1823 | 0.090 |
Why?
|
| Coculture Techniques | 1 | 2012 | 626 | 0.090 |
Why?
|
| Immunoprecipitation | 2 | 2016 | 591 | 0.090 |
Why?
|
| RNA, Long Noncoding | 1 | 2016 | 598 | 0.090 |
Why?
|
| Membrane Potentials | 1 | 2011 | 424 | 0.090 |
Why?
|
| Plasmids | 1 | 2012 | 837 | 0.090 |
Why?
|
| Adenocarcinoma | 3 | 2014 | 7789 | 0.090 |
Why?
|
| Mice, Nude | 3 | 2013 | 4307 | 0.090 |
Why?
|
| Cyclophilins | 1 | 2009 | 32 | 0.090 |
Why?
|
| Organoplatinum Compounds | 1 | 2012 | 702 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 1077 | 0.080 |
Why?
|
| Deoxycytidine | 1 | 2014 | 1353 | 0.080 |
Why?
|
| Down-Regulation | 1 | 2014 | 2074 | 0.080 |
Why?
|
| Cell Line, Transformed | 1 | 2009 | 394 | 0.080 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2018 | 1763 | 0.080 |
Why?
|
| Thioredoxins | 1 | 2008 | 50 | 0.080 |
Why?
|
| Carcinogenesis | 1 | 2014 | 1026 | 0.080 |
Why?
|
| Nitric Oxide | 1 | 2011 | 644 | 0.080 |
Why?
|
| Blotting, Western | 2 | 2012 | 3536 | 0.080 |
Why?
|
| Oxygen Consumption | 1 | 2009 | 401 | 0.080 |
Why?
|
| Radiation, Ionizing | 1 | 2008 | 187 | 0.080 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2011 | 1064 | 0.070 |
Why?
|
| Adaptation, Physiological | 1 | 2009 | 360 | 0.070 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2014 | 3821 | 0.070 |
Why?
|
| Ubiquitin | 2 | 2006 | 344 | 0.070 |
Why?
|
| Vidarabine | 1 | 2012 | 1341 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 2 | 2012 | 5395 | 0.070 |
Why?
|
| Mice, Knockout | 1 | 2016 | 5710 | 0.070 |
Why?
|
| Bronchi | 1 | 2008 | 326 | 0.070 |
Why?
|
| Fibroblasts | 1 | 2013 | 1682 | 0.070 |
Why?
|
| DNA Polymerase gamma | 1 | 2005 | 15 | 0.070 |
Why?
|
| Pyrazines | 2 | 2005 | 495 | 0.070 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2009 | 703 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 2 | 2006 | 507 | 0.060 |
Why?
|
| T-Lymphocytes | 1 | 2018 | 3869 | 0.060 |
Why?
|
| Antioxidants | 1 | 2008 | 507 | 0.060 |
Why?
|
| Molecular Structure | 1 | 2006 | 515 | 0.060 |
Why?
|
| eIF-2 Kinase | 1 | 2005 | 164 | 0.060 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2006 | 363 | 0.060 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2014 | 1724 | 0.060 |
Why?
|
| DNA Primers | 1 | 2005 | 1399 | 0.060 |
Why?
|
| Homeostasis | 1 | 2008 | 950 | 0.060 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2006 | 589 | 0.060 |
Why?
|
| Base Sequence | 1 | 2009 | 4917 | 0.050 |
Why?
|
| Calcium | 2 | 2005 | 1537 | 0.050 |
Why?
|
| Carcinoma | 1 | 2013 | 2578 | 0.050 |
Why?
|
| Melanoma | 1 | 2018 | 5317 | 0.050 |
Why?
|
| Gene Silencing | 2 | 2014 | 837 | 0.050 |
Why?
|
| Piperidines | 1 | 2006 | 1035 | 0.050 |
Why?
|
| Lymphoma | 1 | 2009 | 1467 | 0.050 |
Why?
|
| Tumor Microenvironment | 1 | 2011 | 2864 | 0.050 |
Why?
|
| Disease Progression | 1 | 2011 | 6682 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 3203 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2006 | 2054 | 0.040 |
Why?
|
| Neoplasms, Experimental | 1 | 2002 | 750 | 0.040 |
Why?
|
| Amino Acid Transport System y+ | 1 | 2018 | 31 | 0.040 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2018 | 53 | 0.040 |
Why?
|
| Chemokine CXCL10 | 1 | 2018 | 105 | 0.040 |
Why?
|
| Lipid Peroxidation | 1 | 2018 | 157 | 0.040 |
Why?
|
| Colonic Neoplasms | 1 | 2006 | 1390 | 0.040 |
Why?
|
| Ovarian Neoplasms | 1 | 2013 | 4638 | 0.040 |
Why?
|
| Comet Assay | 1 | 2016 | 59 | 0.040 |
Why?
|
| Oxidants | 1 | 2016 | 49 | 0.040 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2016 | 212 | 0.030 |
Why?
|
| Thapsigargin | 2 | 2005 | 38 | 0.030 |
Why?
|
| Peroxidase | 1 | 2016 | 132 | 0.030 |
Why?
|
| Caspase Inhibitors | 2 | 2005 | 95 | 0.030 |
Why?
|
| Ubiquitination | 1 | 2018 | 575 | 0.030 |
Why?
|
| Oxidative Stress | 2 | 2016 | 1129 | 0.030 |
Why?
|
| RNA Precursors | 1 | 2016 | 137 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2018 | 11538 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 7548 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2016 | 663 | 0.030 |
Why?
|
| Bortezomib | 2 | 2005 | 543 | 0.030 |
Why?
|
| Zebrafish | 1 | 2016 | 463 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2002 | 2045 | 0.030 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2013 | 93 | 0.030 |
Why?
|
| Caspases | 2 | 2005 | 661 | 0.030 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2014 | 249 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2016 | 584 | 0.030 |
Why?
|
| Transcription Factor RelA | 1 | 2013 | 184 | 0.030 |
Why?
|
| Paracrine Communication | 1 | 2013 | 128 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2014 | 905 | 0.030 |
Why?
|
| Cellular Senescence | 1 | 2014 | 382 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 15694 | 0.030 |
Why?
|
| Chemokines | 1 | 2013 | 314 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2018 | 6942 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2013 | 760 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2002 | 3343 | 0.020 |
Why?
|
| Histones | 1 | 2018 | 1466 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2014 | 7226 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2014 | 1869 | 0.020 |
Why?
|
| RNA Interference | 1 | 2014 | 1408 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2018 | 5637 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2013 | 1519 | 0.020 |
Why?
|
| Alleles | 1 | 2016 | 2437 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2013 | 1070 | 0.020 |
Why?
|
| Phosphorylation | 2 | 2006 | 4804 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2014 | 1549 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2013 | 1987 | 0.020 |
Why?
|
| NAD | 1 | 2006 | 89 | 0.020 |
Why?
|
| Tunicamycin | 1 | 2005 | 20 | 0.020 |
Why?
|
| Caspases, Initiator | 1 | 2005 | 16 | 0.020 |
Why?
|
| Transcription Factor CHOP | 1 | 2005 | 25 | 0.020 |
Why?
|
| Cycloheximide | 1 | 2005 | 97 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2005 | 118 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2006 | 328 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2016 | 6150 | 0.020 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2005 | 231 | 0.020 |
Why?
|
| Molecular Chaperones | 1 | 2005 | 264 | 0.020 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2005 | 301 | 0.020 |
Why?
|
| Female | 4 | 2018 | 141928 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2005 | 311 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2005 | 553 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2014 | 5112 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2005 | 15862 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 6207 | 0.010 |
Why?
|
| Cyclin A | 1 | 2002 | 47 | 0.010 |
Why?
|
| Period Circadian Proteins | 1 | 2002 | 52 | 0.010 |
Why?
|
| ARNTL Transcription Factors | 1 | 2002 | 57 | 0.010 |
Why?
|
| Dimerization | 1 | 2002 | 304 | 0.010 |
Why?
|
| Pancreas | 1 | 2005 | 718 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2002 | 682 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2005 | 889 | 0.010 |
Why?
|
| Gamma Rays | 1 | 2002 | 242 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2005 | 803 | 0.010 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2006 | 986 | 0.010 |
Why?
|
| Thymus Gland | 1 | 2002 | 294 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2005 | 2314 | 0.010 |
Why?
|
| Cyclin D1 | 1 | 2002 | 576 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2006 | 1678 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2002 | 622 | 0.010 |
Why?
|
| Cisplatin | 1 | 2005 | 2432 | 0.010 |
Why?
|
| Cell Division | 1 | 2002 | 2489 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2002 | 810 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2002 | 2084 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2002 | 3101 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2002 | 1491 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 21445 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 2488 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 29902 | 0.010 |
Why?
|
| Male | 2 | 2018 | 123000 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2005 | 2992 | 0.010 |
Why?
|
| Phenotype | 1 | 2002 | 6295 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2002 | 5539 | 0.010 |
Why?
|
| Time Factors | 1 | 2002 | 12926 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2002 | 5270 | 0.010 |
Why?
|
| Aged | 1 | 2013 | 70117 | 0.000 |
Why?
|
| Adult | 1 | 2013 | 77950 | 0.000 |
Why?
|
| Middle Aged | 1 | 2013 | 86204 | 0.000 |
Why?
|